Literature DB >> 7054355

Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis.

J M Stuart, M A Cremer, A S Townes, A H Kang.   

Abstract

We have found that serum from rats with type II collagen-induced arthritis, when fractionated with 50% ammonium sulfate and concentrated, would transfer arthritis to nonimmunized recipients. The arthritis in recipients developed within 18-72 h and displayed all of the major histopathologic characteristics of the early lesion in immunized animals but was transient and less severe. Although consideration was given to the possibility that a circulating immune complex was involved, no evidence of such a complex was detected. Further fractionation of the serum yielded an IgG anticollagen antibody that was fully active in transferring disease. The antibody's reaction was inhibited by the native bovine type II collagen used for immunization of donors and the antibody strongly cross-reacted with homologous type II collage but not with denatured collagen. These studies demonstrate that arthritis in rats can be induced with anti-type II collagen antibodies and suggest that an autoimmune process is involved. Because antibodies to collagen have also been detected in human rheumatic diseases, further investigation of the characteristics of collagen antibodies capable of inducing arthritis seems warranted.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7054355      PMCID: PMC2186578          DOI: 10.1084/jem.155.1.1

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  24 in total

1.  Nature of the collagen synthesized by a transplanted chondrosarcoma.

Authors:  B D Smith; G R Martin; E J Miller; A Dorfman; R Swarm
Journal:  Arch Biochem Biophys       Date:  1975-01       Impact factor: 4.013

2.  Passive transfer by cells of type II collagen-induced arthritis in rats.

Authors:  D E Trentham; R A Dynesius; J R David
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

3.  Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes.

Authors:  E Engvall; P Perlmann
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

4.  Transfer of experimental autoimmune thyroiditis by serum from thyroidectomized donors.

Authors:  R M Nakamura; W O Weigle
Journal:  J Exp Med       Date:  1969-08-01       Impact factor: 14.307

5.  Evidence for cell-mediated immunity to collagen in progressive systemic sclerosis.

Authors:  J M Stuart; A E Postlethwaite; A H Kang
Journal:  J Lab Clin Med       Date:  1976-10

6.  Characterization of antibodies to the native human collagens and to their component alpha chains in the sera and the joint fluids of patients with rheumatoid arthritis.

Authors:  N A Andriopoulos; J Mestecky; G P Wright; E J Miller
Journal:  Immunochemistry       Date:  1976-08

7.  Preparation and subfractionation of isologous and heterologous anti-idiotypes, using FV fragments.

Authors:  M Helman; I Shreier; D Givol
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

8.  Demonstration of anticollagen antibodies in rheumatoid arthritis synovial fluids by 14C-radioimmunoassay.

Authors:  J Menzel; C Steffen; G Kolarz; M Kojer; J Smolen
Journal:  Arthritis Rheum       Date:  1978-03

9.  Studies of idiotypic antibodies. Production and characterization of autoantiidiotypic antisera.

Authors:  L S Rodkey
Journal:  J Exp Med       Date:  1974-03-01       Impact factor: 14.307

10.  Autoimmunity to type II collagen an experimental model of arthritis.

Authors:  D E Trentham; A S Townes; A H Kang
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

View more
  81 in total

1.  Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats.

Authors:  S Cuzzocrea; E Mazzon; C Bevilaqua; G Costantino; D Britti; G Mazzullo; A De Sarro; A P Caputi
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Prevention of adjuvant arthritis in rats by a nonapeptide from the 65-kD mycobacterial heat shock protein: specificity and mechanism.

Authors:  X D Yang; J Gasser; U Feige
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

3.  The immune response of guinea-pigs to type II collagen: poor cross-reactivity with homologous type II collagen accounts for resistance to collagen-induced arthritis.

Authors:  A D Hernandez; M A Cremer; A S Townes; J M Stuart; A H Kang
Journal:  Immunology       Date:  1988-04       Impact factor: 7.397

4.  The effect of FK506 and cyclosporin A on antigen-induced arthritis.

Authors:  A Blackham; R J Griffiths
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

5.  Studies on type II collagen induced arthritis in mice.

Authors:  W Paska; K J McDonald; M Croft
Journal:  Agents Actions       Date:  1986-06

6.  A study on type II collagen-induced arthritis in allogeneic bone marrow chimaeras.

Authors:  M Fujita; M Mishima; K Iwabuchi; C Katsume; T Gotohda; K Ogasawara; Y Mizuno; R A Good; K Onoé
Journal:  Immunology       Date:  1989-03       Impact factor: 7.397

7.  Suppression of collagen type II-induced arthritis by transfer of lymphoid cells from rats immunized with collagen.

Authors:  I Burrai; B Henderson; S C Knight; N A Staines
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

8.  Flk-1+ mesenchymal stem cells aggravate collagen-induced arthritis by up-regulating interleukin-6.

Authors:  B Chen; J Hu; L Liao; Z Sun; Q Han; Z Song; R C Zhao
Journal:  Clin Exp Immunol       Date:  2009-12-04       Impact factor: 4.330

9.  Different effect of cyclosporin A on arthritides induced by a muramyl dipeptide analogue or the complete adjuvant in rats.

Authors:  T Sugawara; S Takada; K Furuhama; S Takayama; M Nomura; M Kato
Journal:  Int J Exp Pathol       Date:  1995-06       Impact factor: 1.925

10.  The effects of mesoporphyrin on experimental arthritis in mice.

Authors:  H Nagai; Y Takaoka; H Mori; N Matsuura
Journal:  Inflamm Res       Date:  1996-06       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.